ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13th
July 09 2021 - 8:00AM
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company
applying a precision medicine approach to developing genetically
targeted therapies for cardiovascular diseases, today announced
that Thomas Keuer, Chief Operating Officer, will present at the
Access to Giving Virtual Investor Conference, which is being held
virtually July 13-15, 2021.
Access to Giving is a conference themed around
investor education and advocacy with 50+ companies presenting, a
keynote, three distinctive panels and 1x1 meetings.
ARCA is scheduled to present on Tuesday, July
13, 2021 at 2:00 PM ET. Management will be available for one-on-one
meetings to be held throughout the conference. The presentation
will be webcast live and available for replay at
https://www.webcaster4.com/Webcast/Page/2744/41973.
About ARCA biopharmaARCA
biopharma is dedicated to developing genetically targeted therapies
for cardiovascular diseases through a precision medicine approach
to drug development. ARCA is developing rNAPc2 as a potential
treatment for diseases caused by RNA viruses, initially focusing on
COVID-19. The U.S. FDA has granted Fast Track designation to the
rNAPc2 development program, currently in Phase 2b clinical testing.
ARCA is also developing GencaroTM (bucindolol hydrochloride), an
investigational, pharmacologically unique beta-blocker and mild
vasodilator, as a potential treatment for atrial fibrillation in
heart failure patients. ARCA has identified common genetic
variations that it believes predict individual patient response to
Gencaro, giving it the potential to be the first genetically
targeted AF prevention treatment. The U.S. FDA has granted the
Gencaro development program Fast Track designation and a Special
Protocol Assessment (SPA) agreement. For more information, please
visit www.arcabio.com or follow the Company on LinkedIn.
About Access to GivingAccess to
Giving is the first-of-its-kind virtual investor conference and
will be held July 13th - 15th, 2021. Companies will have the
opportunity to tell their story and conduct 1x1's with qualified
investors for charity. 100% of monies raised through donations for
1x1 meetings will be given to causes that are focused on financial
literacy and financial education.
Investor & Media
Contact:Derek Cole720.940.2163derek.cole@arcabio.com
ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
From Jun 2024 to Jul 2024
ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
From Jul 2023 to Jul 2024